In Brief: Bausch & Lomb
This article was originally published in The Gray Sheet
Bausch & Lomb: Completes $300 mil. cash acquisition of Chiron Vision from Chiron Corp. Plans for the purchase, which gives B&L entry into the refractive laser surgery market, were first announced in October ("The Gray Sheet" Oct. 27, p. 3). Chiron Vision will become part of B&L's new surgical business unit. The completion of B&L's related acquisition of Storz Instrument from parent company American Home Products for $380 mil. in cash was announced Dec. 31...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.